Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glutamate receptor, metabotropic 5 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | rap gtpase-activating protein | 0.0109 | 0.2461 | 0.2461 |
Schistosoma mansoni | serine/threonine protein kinase | 0.011 | 0.2499 | 0.2499 |
Echinococcus granulosus | Vam6:Vps39 protein | 0.0109 | 0.2461 | 0.2076 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.011 | 0.2499 | 0.3154 |
Schistosoma mansoni | vam6/vps39 related | 0.0109 | 0.2461 | 0.2461 |
Brugia malayi | Temporarily assigned gene name protein 59 | 0.0109 | 0.2461 | 0.2461 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.011 | 0.2499 | 0.3154 |
Brugia malayi | Protein kinase domain containing protein | 0.011 | 0.2499 | 0.2499 |
Brugia malayi | hypothetical protein | 0.0109 | 0.2461 | 0.2461 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.2461 | 0.188 |
Trypanosoma cruzi | Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative | 0.0109 | 0.2461 | 0.5 |
Echinococcus granulosus | Serine/threonine-protein kinase Genghis Khan | 0.011 | 0.2499 | 0.2117 |
Schistosoma mansoni | hypothetical protein | 0.0109 | 0.2461 | 0.2461 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.0044 | 0.0592 | 0.0592 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.2461 | 0.188 |
Echinococcus granulosus | GTPase activating Rap:RanGAP domain 3 | 0.0109 | 0.2461 | 0.2076 |
Echinococcus multilocularis | GTPase activating Rap:RanGAP domain 3 | 0.0109 | 0.2461 | 0.3093 |
Trypanosoma cruzi | Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative | 0.0109 | 0.2461 | 0.5 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.0049 | 0.0725 | 0.0725 |
Echinococcus multilocularis | 0.0261 | 0.685 | 1 | |
Schistosoma mansoni | mitogen-activated protein kinase kinase kinase 3 mapkkk3 mekk3 | 0.0109 | 0.2461 | 0.2461 |
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.006 | 0.1051 | 0.0587 |
Trypanosoma brucei | Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative | 0.0109 | 0.2461 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase mig 15 | 0.0368 | 0.9961 | 1 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.0056 | 0.0918 | 0.0918 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.006 | 0.1051 | 0.0875 |
Onchocerca volvulus | 0.0109 | 0.2461 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.2461 | 0.188 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.011 | 0.2499 | 0.2117 |
Loa Loa (eye worm) | STE/STE20/MSN protein kinase | 0.0261 | 0.685 | 0.6632 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1051 | 0.0354 |
Schistosoma mansoni | mitogen-activated protein kinase kinase kinase 3 mapkkk3 mekk3 | 0.0109 | 0.2461 | 0.2461 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.0041 | 0.0495 | 0.0495 |
Echinococcus multilocularis | serine:threonine protein kinase MRCK beta | 0.011 | 0.2499 | 0.3154 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.011 | 0.2499 | 0.2117 |
Schistosoma mansoni | serine/threonine protein kinase | 0.011 | 0.2499 | 0.2499 |
Schistosoma mansoni | protein kinase | 0.011 | 0.2499 | 0.2499 |
Echinococcus granulosus | protein kinase | 0.0261 | 0.685 | 0.6714 |
Schistosoma mansoni | protein kinase | 0.0261 | 0.685 | 0.685 |
Loa Loa (eye worm) | STE/STE20/KHS protein kinase | 0.011 | 0.2499 | 0.1921 |
Loa Loa (eye worm) | hypothetical protein | 0.0368 | 0.9961 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 473 nM | Antagonist activity at human mGluR5 expressed in HEK293 cells assessed as inhibition of Ca2+ mobilization by FLIPR assay | ChEMBL. | 23357634 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.